13 Jan Tchaikapharma High Quality Medicines Inc. received Marketing Authorization for Pizona – a new medicine for diabetes
Tchaikapharma High Quality Medicines Inc. received Marketing Authorization for Pizona – a new medicine for diabetes.
Tchaikapharma High Quality Medicines Inc. received new Marketing Authorization for the medicinal product Pizona 15 mg, Pizona 30 mg and Pizona 45 mg tablets subject to medical prescription.
Pizona contains the active substance pioglitazone and is an anti-diabetic medicine used to treat type 2 (non-insulin dependent) diabetes mellitus. This is the diabetes, which usually occurs in adults.
Pizona helps control the level of blood sugar in type 2 diabetes by helping the body better use the insulin it produces. The attending physician checks whether Pizona is producing the desired effect within 3 to 6 months after initiation of the therapy.
Pizona tablets may be used alone or in combination with metformin and/or sulfonylurea derivatives, which are also oral antidiabetics. The medicament may also be used in combination with insulin.